Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan Yee Lau

Showing results (281-290 of 395) with videos related to

Pageof 40
Sort By:
Annals of Surgical Oncology|February 22, 2011
Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resectionXiao-Feng Zhang, Eric C H Lai, Xiao-Yan Kang, et al.
Surgery|October 20, 2018
Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter studyHan Zhang, Jun Han, Hao Xing, et al.
Journal of Hepatology|November 21, 2017
Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resectionZhengqing Lei, Yong Xia, Anfeng Si, et al.
JAMA Surgery|November 14, 2018
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From ChinaXin-Fei Xu, Hao Xing, Jun Han, et al.
Medicine|March 18, 2016
Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score AnalysisKang Wang, Wei Xing Guo, Min Shan Chen, et al.
The Oncologist|March 13, 2024
Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 AntibodyLei Wang, Jin-Kai Feng, Chong-De Lu, et al.
Annals of Translational Medicine|March 12, 2021
Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomyZong-Tao Chai, Xiu-Ping Zhang, Min Shao, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 8, 2022
A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasionKang Wang, Yan-Jun Xiang, Hong-Ming Yu, et al.
Journal of Cellular Biochemistry|March 30, 2004
Nuclear matrix protein expressions in hepatocytes of normal and cirrhotic rat livers under normal and regenerating conditionsJing-Ping Yun, Choong-Tsek Liew, Eng Ching Chew, et al.
Clinics and Research in Hepatology and Gastroenterology|October 17, 2020
A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinomaJin-Yu Shi, Li-Yang Sun, Bing Quan, et al.
Pageof 40

Showing results (281-290 of 395) with videos related to

Sort By:
Pageof 40
Annals of Surgical Oncology|February 22, 2011
Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resectionXiao-Feng Zhang, Eric C H Lai, Xiao-Yan Kang, et al.
Surgery|October 20, 2018
Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter studyHan Zhang, Jun Han, Hao Xing, et al.
Journal of Hepatology|November 21, 2017
Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resectionZhengqing Lei, Yong Xia, Anfeng Si, et al.
JAMA Surgery|November 14, 2018
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From ChinaXin-Fei Xu, Hao Xing, Jun Han, et al.
Medicine|March 18, 2016
Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score AnalysisKang Wang, Wei Xing Guo, Min Shan Chen, et al.
The Oncologist|March 13, 2024
Salvage Surgery for Initially Unresectable HCC With PVTT Converted by Locoregional Treatment Plus Tyrosine Kinase Inhibitor and Anti-PD-1 AntibodyLei Wang, Jin-Kai Feng, Chong-De Lu, et al.
Annals of Translational Medicine|March 12, 2021
Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomyZong-Tao Chai, Xiu-Ping Zhang, Min Shao, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 8, 2022
A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasionKang Wang, Yan-Jun Xiang, Hong-Ming Yu, et al.
Journal of Cellular Biochemistry|March 30, 2004
Nuclear matrix protein expressions in hepatocytes of normal and cirrhotic rat livers under normal and regenerating conditionsJing-Ping Yun, Choong-Tsek Liew, Eng Ching Chew, et al.
Clinics and Research in Hepatology and Gastroenterology|October 17, 2020
A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinomaJin-Yu Shi, Li-Yang Sun, Bing Quan, et al.
Pageof 40